DKK1 and plasma cell myeloma: Some reports discovered that DKK1 was overexpressed in multiple myeloma, hepatoblastomas, Wilms' tumors, breast cancer and hepatocellular carcinoma (HCC), and functioned as a tumor promoter [7–10].